DSIP 10mg — Vial Spec, Reconstitution Math & COA

Overview of DSIP 10mg Specifications & Inventory Availability

A 10mg vial of DSIP contains ten milligrams of highly purified, lyophilized Delta Sleep-Inducing Peptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) as a stable, vacuum-sealed white cake. Research laboratories typically select the 10mg format for continuous animal model dosing schedules or large-scale comparative assays, minimizing batch-to-batch variation by running extended trials from a single reconstituted stock solution.

Please note: PX1 Research currently stocks DSIP primarily in the standardized DSIP 5mg vial format to ensure optimal reconstitution turnover and prevent unnecessary aqueous degradation over prolonged trial durations. However, for high-throughput screening projects, custom enterprise requests, or custom synthesis batches requiring 10mg fill sizes, institutional buyers can order via our enterprise pipeline or explore alternative research compounds in our catalog hub.

Biochemical Identity and Preclinical Mechanism of Action

Delta Sleep-Inducing Peptide (DSIP) is an amphiphilic nonapeptide first isolated from the cerebral venous blood of rabbits undergoing slow-wave sleep induction. In vitro assays and animal studies indicate that DSIP readily crosses the blood-brain barrier via passive diffusion and specific transport mechanisms, modulating central neuroendocrine activity.

Preclinical literature demonstrates that DSIP primary activity centers on the modulation of delta-wave electroencephalographic (EEG) activity, central stress-axis regulation, and antioxidant enzyme expression. In rodent models, systemic or intracerebroventricular administration of DSIP has been observed to alter corticotropin-like intermediate peptide (CLIP) levels, modulate adrenocorticotropic hormone (ACTH) secretion, and attenuate acute stress responses. Researchers investigating circadian rhythm entrainment and central nervous system homeostasis utilize DSIP to evaluate sleep-architecture modulation and neuronal recovery mechanisms in vitro. For broader literature context on neuroendocrine regulators, consult our comprehensive research library.

Reconstitution Mathematics for 10mg DSIP Vials

Accurate reconstitution is crucial for maintaining exact working concentrations in preclinical trials. When solubilizing a 10mg lyophilized DSIP cake, the resulting concentration depends entirely on the volume of diluent (such as sterile Bacteriostatic Water or physiological saline) added to the vial. Researchers can utilize our online reconstitution calculator to determine exact volumetric requirements for custom lab protocols.

For standard volumetric planning, the concentration math for a 10mg vial is calculated as follows:

• Reconstitution with 1.0 mL Diluent: Yields a final concentration of 10.0 mg/mL (10,000 mcg/mL or 10 mcg per microliter [µL]). This concentrated stock solution is ideal for low-volume micro-injections or deep-freeze aliquot creation.

• Reconstitution with 2.0 mL Diluent: Yields a final concentration of 5.0 mg/mL (5,000 mcg/mL or 5 mcg/µL). This provides an easily measurable concentration for standard laboratory micropipettes.

• Reconstitution with 3.0 mL Diluent: Yields a final concentration of 3.33 mg/mL (3,333 mcg/mL or 3.33 mcg/µL). Useful for larger animal models requiring lower mass concentration per volumetric unit to avoid local tissue overload.

Aliquot Planning and Degradation Mitigation

Like most linear nonapeptides, DSIP in aqueous solution is susceptible to hydrolytic cleavage and peptide aggregation if subjected to repeated freeze-thaw cycles or prolonged room-temperature exposure. Reconstitution of a 10mg vial generates a substantial quantity of liquid stock, making proper aliquot planning vital to preserve compound integrity.

Upon full dissolution of the lyophilized cake using gentle swirl mixing (avoiding vigorous vortexing which introduces shear stress), the primary solution should be divided immediately into single-use, polypropylene microcentrifuge tubes. Aliquots should be sized according to daily assay volume requirements (e.g., 50 µL to 200 µL per tube) and frozen immediately at -20°C or -80°C. Once an aliquot is thawed for lab use, any remaining liquid should be kept at 2°C–8°C and consumed within 24 to 48 hours; un-thawed frozen aliquots remain stable for extended study periods.

Lot-Matched COA Verification and Endotoxin Control

PX1 Research enforces strict quality control standards for all analytical and preclinical reagents. Every lot of DSIP undergoes independent, ISO 17025-accredited third-party laboratory verification to confirm chemical purity, identity, and biological safety before batch release.

Quality testing for DSIP includes High-Performance Liquid Chromatography (HPLC) to verify chemical purity equal to or exceeding 99.0%, and Mass Spectrometry (MS) to confirm the exact theoretical molecular weight of 848.81 Da. Additionally, because central nervous system and cell culture research is highly sensitive to bacterial contaminants, every batch undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to guarantee endotoxin levels remain strictly under <0.01 EU/mg. Investigators can inspect batch-specific documentation directly via our COA lookup portal.

Storage Parameters and Physical Stability Specifications

To maximize shelf life and maintain raw material integrity, laboratories must store DSIP vials according to standardized environmental parameters:

• Lyophilized Powder (Unopened): Store at -20°C in a dry, dark environment. Sealed lyophilized vials remain stable for up to 24 months from the date of manufacture when protected from light and moisture.

• Short-Term Room Temperature Stability: Lyophilized vials can tolerate ambient transit conditions (up to 37°C) for several days during shipping without degradation, supported by cold-chain dispatch protocols from our CA and AZ facilities.

• Reconstituted Liquid Solution: Store at 2°C to 8°C for short-term use (up to 7 days). For long-term storage, frozen aliquots stored at -80°C maintain structural integrity for up to 12 months, provided thermal fluctuation is minimized.

Comparative Class Analysis: DSIP vs. Related Neuroendocrine Peptides

When designing protocols around neurochemical regulation, stress response, or circadian entrainment, researchers frequently evaluate DSIP alongside other synthetic and endogenous regulatory peptides. Understanding how these compounds differ in target selectivity helps refine experimental design.

While DSIP targets delta-wave sleep induction and central stress-axis regulation via neuromodulatory pathways, Epitalon acts primarily on the pineal gland to regulate melatonin synthesis and telomerase activity. Similarly, central nervous system modulators like Selank and Semax target gabaergic and neurotrophic factor (BDNF/TrkB) pathways to influence anxiety and cognitive processing rather than direct slow-wave sleep architecture. Combining these distinct mechanisms allows researchers to isolate specific physiological cascades within neuroendocrine study models.

Selecting the Optimal Format: 5mg vs. 10mg Protocols

Choosing between a 5mg and a 10mg DSIP vial size depends on experimental scale, laboratory throughput, and handling capacity. While a 10mg format offers unit-cost efficiency for high-volume automated liquid handling systems, smaller fill sizes often present practical advantages for lower-throughput studies.

If a laboratory runs low-frequency assays or small rodent sample sizes, reconstituted 10mg stock solutions may remain in liquid storage longer than optimal, increasing the risk of hydrolytic decay or accidental contamination. In such cases, utilizing multiple DSIP 5mg vials allows researchers to reconstitute smaller, fresher batches as needed, preserving peak purity across long-term experimental timelines. High-volume institutional buyers requiring custom large-scale packaging can arrange bulk supply contracts through our dedicated wholesale division.